mifepristone has been researched along with Cancer of Testis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Check, D; Check, JH; Dix, E; Wilson, C | 1 |
| DeMayo, FJ; Matzuk, MM; Omalley, BW; Pierson, TM; Tsai, SY; Wang, Y | 1 |
2 other study(ies) available for mifepristone and Cancer of Testis
| Article | Year |
|---|---|
Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies.
Topics: Animals; Antineoplastic Agents; Female; Hormone Antagonists; Male; Mice; Mice, Inbred C57BL; Mifepristone; Pregnancy; Progesterone; Prostatic Neoplasms; Receptors, Progesterone; Testicular Neoplasms | 2010 |
Regulable expression of inhibin A in wild-type and inhibin alpha null mice.
Topics: Animals; Cell Line; Female; Follicle Stimulating Hormone; Genetic Engineering; Inhibins; Liver; Male; Mice; Mice, Knockout; Mice, Mutant Strains; Mifepristone; Neoplasms, Experimental; Ovary; Peptides; Pituitary Gland; Promoter Regions, Genetic; Testicular Neoplasms; Testis | 2000 |